AARTIPHARM.NSAARTIPHARM.NSNSE
Loading
Net Income ScalingExpanding
Percentile Rank100
3Y CAGR+30.6%
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

3Y CAGR
+30.6%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.2x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$2.72B+25.6%
2024$2.17B+12.1%
2023$1.93B+58.3%
2022$1.22B+2660045.6%
2021$-45960.00+75.4%
2020$-187000.00-